
Opinion|Videos|August 14, 2024
Monitoring Response in Immune Checkpoint Inhibitor-Based RCC Therapy
Medical experts examine strategies for monitoring treatment response in patients initiating first-line immune checkpoint inhibitor-based therapy for metastatic renal cell carcinoma.
Episodes in this series





































